Literature DB >> 16732377

Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators.

Maria Nilsson1, Ole E Sørensen, Matthias Mörgelin, Maria Weineisen, Ulf Sjöbring, Heiko Herwald.   

Abstract

Streptococcus pyogenes is an important Gram-positive pathogen that is strictly limited to infections in humans. Here we report that streptolysin O (SLO), a cytolytic exotoxin secreted by S. pyogenes, activates human polymorphonuclear neutrophils (PMNs) by perforating these cells. This appears to be followed by an influx of Ca(2+) and p38 MAPK activation. As a consequence, PMNs secrete heparin-binding protein, a potent inducer of vascular leakage, and neutrophil-borne proteins, including LL-37, alpha-defensins, and elastase. The results of the present work therefore suggest that the interaction between SLO and PMNs evokes an exaggerated host response which may contribute to the pathogenesis of local and generalized S. pyogenes infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732377     DOI: 10.1160/TH05-08-0572

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  The Cholesterol-dependent Cytolysin Membrane-binding Interface Discriminates Lipid Environments of Cholesterol to Support β-Barrel Pore Insertion.

Authors:  Allison J Farrand; Eileen M Hotze; Takehiro K Sato; Kristin R Wade; William C Wimley; Arthur E Johnson; Rodney K Tweten
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

2.  The pore-forming toxin listeriolysin O is degraded by neutrophil metalloproteinase-8 and fails to mediate Listeria monocytogenes intracellular survival in neutrophils.

Authors:  Eusondia Arnett; Stephen Vadia; Colleen C Nackerman; Steve Oghumu; Abhay R Satoskar; Kenneth R McLeish; Silvia M Uriarte; Stephanie Seveau
Journal:  J Immunol       Date:  2013-12-06       Impact factor: 5.422

3.  CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1.

Authors:  Y Jerold Gordon; Eric G Romanowski; Robert M Q Shanks; Kathleen A Yates; Heather Hinsley; H Anne Pereira
Journal:  Curr Eye Res       Date:  2009-03       Impact factor: 2.424

4.  LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like Structures with Immune Stimulatory Properties.

Authors:  Julia Uhlmann; Manfred Rohde; Nikolai Siemens; Bernd Kreikemeyer; Peter Bergman; Linda Johansson; Anna Norrby-Teglund
Journal:  J Innate Immun       Date:  2015-12-08       Impact factor: 7.349

5.  High alpha-defensin levels in patients with systemic lupus erythematosus.

Authors:  Zev M Sthoeger; Shira Bezalel; Nava Chapnik; Ilan Asher; Oren Froy
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 6.  Playing With Fire: Proinflammatory Virulence Mechanisms of Group A Streptococcus.

Authors:  Shyra Wilde; Anders F Johnson; Christopher N LaRock
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

Review 7.  More than a pore: the cellular response to cholesterol-dependent cytolysins.

Authors:  Sara K B Cassidy; Mary X D O'Riordan
Journal:  Toxins (Basel)       Date:  2013-04-12       Impact factor: 4.546

Review 8.  Inflammasome/IL-1β Responses to Streptococcal Pathogens.

Authors:  Christopher N LaRock; Victor Nizet
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

Review 9.  Host responses to group a streptococcus: cell death and inflammation.

Authors:  James A Tsatsaronis; Mark J Walker; Martina L Sanderson-Smith
Journal:  PLoS Pathog       Date:  2014-08-28       Impact factor: 6.823

10.  Suilysin Stimulates the Release of Heparin Binding Protein from Neutrophils and Increases Vascular Permeability in Mice.

Authors:  Shaolong Chen; Wenlong Xie; Kai Wu; Ping Li; Zhiqiang Ren; Lin Li; Yuan Yuan; Chunmao Zhang; Yuling Zheng; Qingyu Lv; Hua Jiang; Yongqiang Jiang
Journal:  Front Microbiol       Date:  2016-08-26       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.